These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 563721)

  • 1. Deoxyribonucleoside triphosphate pools and adenosine toxicity.
    Smyth JF; Harrap KR
    Biochem Pharmacol; 1977 Dec; 26(24):2371-4. PubMed ID: 563721
    [No Abstract]   [Full Text] [Related]  

  • 2. In vivo inhibition of adenosine deaminase by 2'-deoxycoformycin in mouse blood and leukemia L1210 cells.
    Agarwal RP
    Biochem Pharmacol; 1980 Feb; 29(2):187-93. PubMed ID: 6965857
    [No Abstract]   [Full Text] [Related]  

  • 3. Evaluation of ribonucleoside and deoxyribonucleoside triphosphate pools in cultured leukemia cells during exposure to methotrexate or methotrexate plus thymidine.
    Kinahan JJ; Otten M; Grindey GB
    Cancer Res; 1979 Sep; 39(9):3531-9. PubMed ID: 476679
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Potentiation by 2'-deoxycoformycin of the inhibitory effect of xylosyladenine on nuclear RNA synthesis in L1210 cells in vitro.
    Peale AL; Glazer RI
    Biochem Pharmacol; 1978; 27(21):2543-7. PubMed ID: 728208
    [No Abstract]   [Full Text] [Related]  

  • 5. Biochemical properties of the nucleoside of 3-amino-1,5-dihydro-5-methyl-1,4,5,6,8-pentaazaacenaphthylene (NSC-154020).
    Bennett LL; Smithers D; Hill DL; Rose LM; Alexander JA
    Biochem Pharmacol; 1978 Jan; 27(2):233-41. PubMed ID: 564191
    [No Abstract]   [Full Text] [Related]  

  • 6. Tight-binding inhibitors-II. Non-steady state nature of inhibition of milk xanthine oxidase by allopurinol and alloxanthine and of human erythrocytic adenosine deaminase by coformycin.
    Cha S; Agarwal RP; Parks RE
    Biochem Pharmacol; 1975 Dec; 24(23):2187-97. PubMed ID: 1212267
    [No Abstract]   [Full Text] [Related]  

  • 7. Kinetics of N-(phosphonacetyl)-L-aspartate and pyrazofurin depletion of pyrimidine ribonucleotide and deoxyribonucleotide pools and their relationship to nucleic acid synthesis in intact and permeabilized cells.
    Moyer JD; Smith PA; Levy EJ; Handschumacher RE
    Cancer Res; 1982 Nov; 42(11):4525-31. PubMed ID: 7127293
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of nucleoside transport in drug action. The adenosine deaminase inhibitor, deoxycoformycin, and the antiplatelet drugs, dipyridamole and dilazep.
    Parks RE; Dawicki DD; Agarwal KC; Chen SF; Stoeckler JD
    Ann N Y Acad Sci; 1985; 451():188-203. PubMed ID: 3878117
    [No Abstract]   [Full Text] [Related]  

  • 9. Purine deoxyribonucleoside induced hepatotoxicity in the mouse.
    Renshaw J; Paine RM; Taylor GA; Harrap KR
    Adv Exp Med Biol; 1984; 165 Pt B():363-6. PubMed ID: 6609540
    [No Abstract]   [Full Text] [Related]  

  • 10. Deoxyadenosine metabolism and toxicity in cultured L5178Y cells.
    Lowe JK; Gowans B; Brox L
    Cancer Res; 1977 Sep; 37(9):3013-7. PubMed ID: 301772
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tight-binding inhibitors--III. A new approach for the determination of competition between tight-binding inhibitors and substrates--inhibition of adenosine deaminase by coformycin.
    Cha S
    Biochem Pharmacol; 1976 Dec; 25(24):2695-702. PubMed ID: 1008893
    [No Abstract]   [Full Text] [Related]  

  • 12. Adenosine metabolism in cultured lymphoid cells.
    Harrap KR; Paine RM
    Adv Enzyme Regul; 1976; 15():169-93. PubMed ID: 1030182
    [No Abstract]   [Full Text] [Related]  

  • 13. Adenosine and guanosine metabolism during phytohemagglutinin induced transformation of human lymphocytes.
    Snyder FF; Mendelsohn J; Seegmiller JE
    Adv Exp Med Biol; 1977; 76A():441-7. PubMed ID: 404852
    [No Abstract]   [Full Text] [Related]  

  • 14. Effect of methotrexate and 1-beta-D-arabinofuranosylcytosine on pools of deoxyribonucleoside triphosphates in L1210 ascites cells.
    Roberts D; Peck C
    Cancer Res; 1981 Feb; 41(2):505-10. PubMed ID: 7448798
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Study of the cytotoxicity and metabolism of 4-amino-3-carboxamido-1-(beta-D-ribofuranosyl)pyrazolo[3,4-d]pyrimidine using inhibitors of adenosine kinase and adenosine deaminase.
    Wotring LL; Townsend LB
    Cancer Res; 1979 Aug; 39(8):3018-23. PubMed ID: 222442
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of K and NK lymphocyte cytotoxicity by an inhibitor of adenosine deaminase and deoxyadenosine.
    Grever MR; Siaw MF; Coleman MS; Whisler RL; Balcerzak SP
    J Immunol; 1983 Jan; 130(1):365-9. PubMed ID: 6600187
    [No Abstract]   [Full Text] [Related]  

  • 17. Factors determining cell sensitivity to methotrexate: studies of folate and deoxyribonucleoside triphosphate pools in five mammalian cell lines.
    Tattersall MH; Jackson RC; Jackson ST; Harrap KR
    Eur J Cancer (1965); 1974 Dec; 10(12):819-26. PubMed ID: 4549304
    [No Abstract]   [Full Text] [Related]  

  • 18. Deoxyadenosine triphosphate accumulation in erythrocytes of deoxycoformycin-treated mice.
    Smith CM; Henderson JF
    Biochem Pharmacol; 1982 Apr; 31(8):1545-51. PubMed ID: 6980005
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of maturation of human precursor lymphocytes by coformycin, an inhibitor of the enzyme adenosine deaminase.
    Ballet JJ; Insel R; Merler E; Rosen FS
    J Exp Med; 1976 May; 143(5):1271-6. PubMed ID: 1262787
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Biochemical changes induced in hairy-cell leukemia following treatment with the adenosine deaminase inhibitor 2'-deoxycoformycin.
    Johnston JB; Begleiter A; Pugh L; Leith MK; Wilkins JA; Cavers DJ; Israels LG
    Cancer Res; 1986 Apr; 46(4 Pt 2):2179-84. PubMed ID: 2418965
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.